Research
Hormonal
Tirzepatide treatment shows a potent glucose-lowering effect and promotes weight loss with minimal GI adverse effects.
Tirzepatide may be considered for patients needing effective glucose control and weight loss with fewer gastrointestinal side effects.
StrongSupportsmedium confidence
Tirzepatide treatment showed a potent glucose-lowering effect and promoted weight loss with minimum GI adverse effects in animal studies as well as phase I and II human trials.
Why this rating
The claim is based on findings from human trials.
Source
Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
Bhaskar Pal et al. · Journal of Diabetology · 2024
reviewCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →